Table 19.
Most frequent agent exposures in cardiovascular class age > 65
| N (%)a | |
|---|---|
| Metoprolol | 16 (21.6) |
| Digoxin | 15 (20.3) |
| Amlodipine | 7 (9.5) |
| Amiodarone | 4 (5.4) |
| Diltiazem | 4 (5.4) |
| Atenolol | 3 (4.1) |
| Lisinopril | 3 (4.1) |
| Verapamil | 3 (4.1) |
| Carvedilol | 2 (2.7) |
| Flecainide | 2 (2.7) |
| Isosorbide | 2 (2.7) |
| Propranolol | 2 (2.7) |
| Sotalol | 2 (2.7) |
| Atorvastatin | 1 (1.4) |
| Clonidine | 1 (1.4) |
| Enalapril | 1 (1.4) |
| Hydralazine | 1 (1.4) |
| Lercanidipine | 1 (1.4) |
| Nadolol | 1 (1.4) |
| Nebivolol | 1 (1.4) |
| Nifedipine | 1 (1.4) |
| Tamsulosin | 1 (1.4) |
| Class total | 74 (100) |
aPercentages are out of total number of cardiovascular agent exposures reported in adults aged > 65 in 2018 (N = 74)